SPHK2 and arthritic joint disease: Conversely, the genetic deletion of Sphk2 showed minor effects on disease progression in the mouse model of TNF-α-induced arthritis, whereas the pharmacologic inhibition with the SPHK2 inhibitor ABC294640 augmented disease severity [79].